What is new and promising with drug-eluting stents in sinus surgery

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 22, Issue 1, 2014, Pages 2-7

  Campbell, Raewyn G ^a   Kennedy, David W ^b  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

bioabsorbable; endoscopic sinus surgery; implant; steroid releasing

Indexed keywords

CHRONIC DISEASE; DRUG-ELUTING STENTS; HUMANS; RHINITIS; SINUSITIS; STEROIDS;

EID: 84895074349     PISSN: 10689508     EISSN: 15316998     Source Type: Journal    
DOI: 10.1097/MOO.0000000000000012     Document Type: Review

References (36)

1. Leung RM, Kern RC, Conley DB, et al. Osteomeatal complex obstruction is not associated with adjacent sinus disease in chronic rhinosinusitis with polyps. Am J Rhinol Allergy 2011; 25:401-403.
2. Snidvongs K CD, Sacks R, Earls P, Harvey RJ. Eosinophilic rhinosinusitis is not a disease of ostiomeatal occlusion. Laryngoscope 2013; 123:1070- 1074.
3. Senior BA, Kennedy DW, Tanabodee J, et al. Long-term results of functional endoscopic sinus surgery. Laryngoscope 1998; 108:151-157.
4. Kennedy DW. Prognostic factors, outcomes and staging in ethmoid sinus surgery. Laryngoscope 1992; 102 (12 pt 2 Suppl 57):1-18.
5. Kennedy DW, Wright ED, Goldberg AN. Objective and subjective outcomes in surgery for chronic sinusitis. Laryngoscope 2000; 110 (Suppl 94):29-31.
6. Matsuwaki Y, Ookushi T, Asaka D, et al. Chronic rhinosinusitis: Risk factors for the recurrence of chronic rhinosinusitis based on 5-year follow-up after endoscopic sinus surgery. Int Arch Allergy Immunol 2008; 146 (Suppl 1): 77-81.
7. Stoop AE, van der Heijden HA, Biewenga J, van der Baan S. Eosinophils in nasal polyps and nasal mucosa: An immunohistochemical study. J Allergy Clin Immunol 1993; 91:616-622.
8. Myller JP, Toppila-Salmi SK, Toppila EM, et al. Mucosal eosinophils and l-selectin ligands are associated with invasive and noninvasive sinus surgery outcomes. Am J Rhinol Allergy 2009; 23:21-27.
9. Smith TL, Litvack JR, Hwang PH, et al. Determinants of outcomes of sinus surgery: A multiinstitutional prospective cohort study. Otolaryngol Head Neck Surg 2010; 142:55.
10. Soler ZM, Sauer D, Mace J, Smith TL. Impact of mucosal eosinophilia and nasal polyposis on quality-of-life outcomes after sinus surgery. Otolaryn gol Head Neck Surg 2010; 142:64-71.
11. Bugten V, Norgard S, Steinsvag S. The effects of debridement after endoscopic sinus surgery. Laryngoscope 2006; 116:2037-2043.
12. Otto KJ, DelGaudio JM. Operative findings in the frontal recess at time of revision surgery. Am J Otolaryngol 2010; 31:175-180.
13. Rudmik L, Soler ZM, Orlandi RR, et al. Early postoperative care following endoscopic sinus surgery: An evidence-based review with recommendations. Int Forum Allergy Rhinol 2011; 1:417-430.
14. Poetker DM, Smith TL. What rhinologists and allergists should know about the medico-legal implications of corticosteroid use: A review of the literature. Int Forum Allergy Rhinol 2012; 2:95-103.
15. Hosemann W, Wigand ME, Gode U, et al. Normal wound healing of the paranasal sinuses; clinical and experimental investigations. Eur Arch Otorhinolaryngol 1991; 248:390-394.
16. Beule AG, Steinmeier E, Kaftan H, et al. Effects of a dexamethasone-releasing stent on osteoneogenesis in a rabbit model. Am J Rhinol Allergy 2009; 23:433-436.
17. Beule AG, Scharf C, Biebler KE, et al. Effects of topically applied dexamethasone on mucosal wound healing using a drug-releasing stent. Laryngoscope 2008; 118:2073-2077.
18. Cote DW, Wright ED. Triamcinolone-impregnated nasal dressing following endoscopic sinus surgery: A randomized, double-blind, placebo-controlled study. Laryngoscope 2010; 120:1269-1273.
19. Lipworth BJ, Jackson CM. Safety of inhaled and intranasal corticosteroids: Lessons for the new millennium. Drug Saf 2000; 23:11-33.
20. Weber RK. Nasal packing and stenting. GMS Curr Top Otorhinolarygnol Head Neck Surg 2009; 8:; doc02.
21. Murr AH, Smith TL, Hwang PH, et al. Safety and efficacy of a novel bioabsorbably, steroid-eluting sinus stent. Int Forum Allergy Rhinol 2011; 1:23-32.
22. Intersect ENT. http://www.intersectent.com/advantage-how-it-works.html. [Accessed 10 September 2013]
23. Li PM, Downie D, Hwang PH. Controlled steroid delivery via bioabsorbable stent: Safety and performance in a rabbit model. Am J Rhinol Allergy 2009; 23:591-596.
24. Onrust SV, Lamb HM. Mometasone furoate. A review of its intranasal use in allergic rhinitis. Drugs 1998; 56:725-745.
25. Forthwith KD, Chandra RK, Yun PT, et al. ADVANCE: A multisite trial of bioabsorbable steroid-eluting sinus implants. Laryngoscope 2011; 121: 2473-2480.
26. Marple BF, Smith TL, Han JK, et al. ADVANCE II: A prospective, randomized study assessing safety and efficacy of bioabsorbable steroid-releasing sinus implants. Otolaryngol Head Neck Surg 2012; 146:1004-1011
27. Han JK, Marple BF, Smith TL, et al. Effect of steroid-releasing sinus implants on postoperative medical and surgical interventions: An efficacy meta-analysis. Int Forum Allergy Rhinol 2012; 2:271-279.
28. Hoffman DF, May M, Mester SJ. Functional endoscopic sinus surgery - experience with the initial 100 patients. Am J Rhinol 1990; 4:129-132.
29. Jakobsen J, Svendstrup F. Functional endoscopic sinus surgery in chronic sinusitis - a series of 237 consecutively operated patients. Acta Otolarynogl Suppl 2000; 543:158-161.
30. Tran KN, Buele AG, Singal D, Wormald PJ. Frontal ostium restenosis after the endoscopic modified Lothrop procedure. Laryngoscope 2007; 117:1457- 1462.
31. Smith TL, Mendolia-Loffredo S, Loehrl TA, et al. Predictive factors and outcomes in endoscopic sinus surgery for chronic rhinosinusitis. Laryngoscope 2005; 115:2199-2205.
32. Villari CR, Wojno TJ, DelGaudio JM. Case report of orbital violation with placement of ethmoid drug-eluting stent. Int Forum Allergy Rhinol 2012; 2:89-92.
33. Sjogren PP, Parker NP, Boyer HC. Retained drug-eluting stents and recalcitrant chronic rhinosinusitis: A case report. Allergy Rhinol 2013; 4:e45-e48.
34. Catalano PJ, Thong M, Weiss R, Rimash T. The microflow spacer: A drugeluting stent for the ethmoid sinus. Indian J Otolaryngol Head Neck Surg 2011; 63:279-284.
35. Cortese B, Bertoletti A. Paclitaxel coated balloons for coronary artery interventions: A comprehensive review of preclinical and clinical data. Int J Cadiol 2012; 161:4-12.
36. Axel DI, Kunert W, Goggelmann C, et al. Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery. Circulation 1997; 96:636-645.